Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sobhan Medicine Trade Development (SMTD) is a prominent Iranian pharmaceutical company and a key subsidiary of the Barkat Pharmaceutical Group. The company specializes in the international procurement, distribution, and trade of pharmaceutical raw materials, active pharmaceutical ingredients (APIs), and finished dosage forms. SMTD plays a critical role in the Iranian healthcare supply chain by facilitating the import of essential medicines and the export of locally manufactured products to regional markets. Its operations support a wide range of therapeutic areas, including oncology, cardiovascular health, and infectious diseases. As part of the larger Tadbir Economic Development Group, SMTD leverages extensive logistics and regulatory expertise to enhance national health security and expand the global reach of Iranian pharmaceuticals.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sobhan Medicine Trade Development.